文献速递心力衰竭与心肌病

衰弱状态改变HFrEF患者有氧运动训练疗效:HF-ACTION试验分析

Frailty Status Modifies the Efficacy of Exercise Training Among Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the HF-ACTION Trial.
PubMed 文献 · Circulation · 2022-05-26

该分析基于HF-ACTION试验中2130例稳定HFrEF门诊患者,用Rockwood衰弱指数评估基线衰弱,检验衰弱是否修饰有氧运动训练对主要复合终点(全因住院或死亡)的疗效。结果显示衰弱显著修饰疗效:衰弱者主要终点风险降低(HR 0.83,95%CI 0.72-0.95),非衰弱者无获益(HR 1.04,95%CI 0.87-1.25),获益主要由全因住院减少驱动,死亡率无差异。

要点

  • 基线衰弱(FI>0.21)的HFrEF患者从有氧运动训练中主要终点获益更明显。
  • 衰弱者全因住院风险显著降低(HR 0.84,95%CI 0.72-0.99),非衰弱者无此获益。
  • 有氧运动训练对全因死亡及多数次要终点的影响在衰弱与非衰弱患者间无差异。

核心结论

  • 在慢性稳定HFrEF患者中,基线衰弱修饰有氧运动训练的治疗效应,衰弱者全因住院风险降低更明显,但死亡率无差异。

研究设计与样本

  • HF-ACTION试验的事后分析,纳入随机接受有氧运动训练或常规照护的稳定HFrEF门诊患者2130例(年龄59±13岁,28%女性)。
  • 用Rockwood衰弱指数评估基线衰弱,FI>0.21定义为衰弱,共1266例(59%)为衰弱。
  • 采用含衰弱×治疗组交互项的多变量Cox比例风险模型,分别以连续FI和分类衰弱状态建模。

主要发现

  • 衰弱显著修饰有氧运动训练对主要复合终点(全因住院或死亡)的效应:FI×治疗组P交互=0.02,衰弱状态×治疗组P交互=0.04。
  • 衰弱者有氧运动训练主要终点风险降低(HR 0.83,95%CI 0.72-0.95),非衰弱者无获益(HR 1.04,95%CI 0.87-1.25)。
  • 衰弱者获益主要来自全因住院风险降低(HR 0.84,95%CI 0.72-0.99)。
  • 有氧运动训练对全因死亡及其他次要终点的影响在衰弱与非衰弱间无差异(各项P交互>0.1)。
  • 衰弱者3个月KCCQ评分改善名义上更大,但衰弱状态的治疗交互无统计学意义(P交互>0.2)。

关键数值与推荐

  • 衰弱定义:Rockwood衰弱指数FI>0.21。
  • 主要复合终点:全因住院或死亡;次要终点包括心血管死亡或心血管住院复合、心血管死亡或心衰住院复合,以及KCCQ评分。

临床怎么用

  • 对稳定HFrEF门诊患者评估基线衰弱,可识别更可能从有氧运动训练中减少全因住院的亚组。
  • 衰弱患者可从有氧运动训练中获主要终点获益,非衰弱患者的主要终点未见获益。
  • 有氧运动训练未显示降低死亡风险,宣教时应聚焦住院相关获益。

局限性

  • 为HF-ACTION试验的事后分析,结论属探索性。
  • 衰弱用Rockwood FI评估,FI>0.21为研究采用的定义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Supervised aerobic exercise training (ET) is recommended for stable outpatients with heart failure (HF) with reduced ejection fraction (HFrEF). Frailty, a syndrome characterized by increased vulnerability and decreased physiologic reserve, is common in patients with HFrEF and associated with a higher risk of adverse outcomes. The effect modification of baseline frailty on the efficacy of aerobic ET in HFrEF is not known. METHODS: Stable outpatients with HFrEF randomized to aerobic ET versus usual care in the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) trial were included. Baseline frailty was estimated using the Rockwood frailty index (FI), a deficit accumulation-based model of frailty assessment; participants with FI scores >0.21 were identified as frail. Multivariable Cox proportional hazard models with multiplicative interaction terms (frailty × treatment arm) were constructed to evaluate whether frailty modified the treatment effect of aerobic ET on the primary composite end point (all-cause hospitalization or mortality), secondary end points (composite of cardiovascular death or cardiovascular hospitalization, and cardiovascular death or HF hospitalization), and Kansas City Cardiomyopathy Questionnaire score. Separate models were constructed for continuous (FI) and categorical (frail versus not frail) measures of frailty. RESULTS: Among 2130 study participants (age, 59±13 years; 28% women), 1266 (59%) were characterized as frail (FI>0.21). Baseline frailty burden significantly modified the treatment effect of aerobic ET (P interaction: FI × treatment arm=0.02; frail status [frail versus nonfrail] × treatment arm=0.04) with a lower risk of primary end point in frail (hazard ratio [HR], 0.83 [95% CI, 0.72-0.95]) but not nonfrail (HR, 1.04 [95% CI, 0.87-1.25]) participants. The favorable effect of aerobic ET among frail participants was driven by a significant reduction in the risk of all-cause hospitalization (HR, 0.84 [95% CI, 0.72-0.99]). The treatment effect of aerobic ET on all-cause mortality and other secondary endpoints was not different between frail and nonfrail patients (P interaction>0.1 for each). Aerobic ET was associated with a nominally greater improvement in Kansas City Cardiomyopathy Questionnaire scores at 3 months among frail versus nonfrail participants without a significant treatment interaction by frailty status (P interaction>0.2). CONCLUSIONS: Among patients with chronic stable HFrEF, baseline frailty modified the treatment effect of aerobic ET with a greater reduction in the risk of all-cause hospitalization but not mortality.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Pandey, Segar, Singh, et al. Frailty Status Modifies the Efficacy of Exercise Training Among Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the HF-ACTION Trial. Circulation. 2022. PMID: 35616018. doi:10.1161/CIRCULATIONAHA.122.059983

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。